| CURIS INC. DL -,01 |
| USA |
| Gesundheit |
| US2312693094 / A3ETJD |
| CUS0 (Frankfurt) / CRIS (NASDAQ) |
| FRA:CUS0, ETR:CUS0, CUS0:GR, NASDAQ:CRIS |
| - |
| https://www.curis.com/ |
|
Curis Inc. is a biotechnology company focused on the development and commercialization of therapeutic drugs for the treatment of cancer. The company's primary mission is to enhance patient outcomes th..
>Volltext.. |
| 9.67 Mio. EUR |
| 27.85 Mio. EUR |
| 10.06 Mio. EUR |
| -29.52 Mio. EUR |
| -31.57 Mio. EUR |
| -3.18 EUR |
| 26.43 Mio. EUR |
| 7.82 Mio. EUR |
| -25.99 Mio. EUR |
| 0.45 |
| 7.75% |
| 23.74% |
| - |
| - |
| - |
| - |
| CURIS |
| 20.03.26 |
|